CRP and metabolic disease: Several serum biomarkers used to evaluate inflammation, such as pro-inflammatory cytokines and C-reactive protein (CRP), are also markers of physiological dysregulation and are used to estimate the risks for various diseases, particularly cardiovascular and metabolic diseases [8].